Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2005

Gavrilova S I, Kolykhalov I V, Korovaĭtseva G I, Zharikov G A, Kalyn Ia B, Selezneva N D

Abstract excerpt

Correlation association between an ApoE4 genotype in patients with mild-moderate Alzheimer's disease and efficacy of neurotrophic (cerebrolysin) and cholinergic (exelon) therapy was studied in the groups of patients formed using case-control method. A 4-month treatment has shown that both types of therapy had a significant clinical effect, however clinical effect proved to be more higher and stable in patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activities of Daily Living
Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Amino Acids

Share to Apolipoproteins E

Share to Cholinesterase Inhibitors

Share to Follow-Up Studies

Share to Nerve Growth Factors

Share to Neuropsychological Tests

Source

Identifiers

PMID: 15880838

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[ApoE genotype and efficacy of neurotrophic and cholinergic therapy in Alzheimer's disease].PMID 15880838Read ↗

[Pharmacological approaches to the therapy of Alzheimer's disease].Semantic proximity Read ↗

[Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer's disease: the role of the ApoE genotype].Semantic proximity Read ↗

Apolipoprotein E genotype and gender influence response to tacrine therapy.Semantic proximity Read ↗

Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.Semantic proximity Read ↗

Effect of APOE and CHRNA7 genotypes on the cognitive response to cholinesterase inhibitor treatment at different stages of Alzheimer's disease.Semantic proximity Read ↗

[Citicoline in the treatment of cognitive impairment in first-degree relatives of AD patients: the influence of the ApoE genotype].Semantic proximity Read ↗

[Polymorphism of APOE gene and risk of development of the multiple sclerosis at ethnic Russians].Semantic proximity Read ↗

[Effect of anticholinergic drugs on cognitive impairment in the elderly].Semantic proximity Read ↗

Tacrine and rate of progression in Alzheimer's disease--relation to ApoE allele genotype.Semantic proximity Read ↗

Cerebrolysin in Alzheimer's disease: a randomized, double-blind, placebo-controlled trial with a neurotrophic agent.Semantic proximity Read ↗

Association of refractory complex partial seizures with a polymorphism of ApoE genotype.Semantic proximity Read ↗

[Nicotine and neurologic diseases--even a noxious substance may possess beneficial properties].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.